Copyright
©2010 Baishideng.
World J Gastrointest Surg. Jun 27, 2010; 2(6): 203-206
Published online Jun 27, 2010. doi: 10.4240/wjgs.v2.i6.203
Published online Jun 27, 2010. doi: 10.4240/wjgs.v2.i6.203
Table 1 Result of the clinical trial of SN mapping for gastric cancer conducted by The Japan Society of Sentinel Node Navigation Surgery study group[4]
| Factors | n (%) |
| SN identification (n = 397) | |
| Undetected | 10 (2.5) |
| Detected | 387 (97.5) |
| Mean No. of identified SN | 5.5/case |
| pN factor (n = 387) | |
| pN (+) | 57 (15) |
| pN (-) | 330 (85) |
| SN metastasis (n = 57) | |
| pSN (+) | 53 (93) |
| pSN (-) | 4 (7) |
| SN/non-SN metastatic status (n = 387) | |
| SN (+)/non-SN (-) | 32 (8) |
| SN (+)/non-SN (+) | 21 (5) |
| SN (-)/non-SN (-) | 330 (85) |
| SN (-)/non-SN (+) | 4 (1) |
- Citation: Asakuma M, Cahill RA, Lee SW, Nomura E, Tanigawa N. NOTES: The question for minimal resection and sentinel node in early gastric cancer. World J Gastrointest Surg 2010; 2(6): 203-206
- URL: https://www.wjgnet.com/1948-9366/full/v2/i6/203.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v2.i6.203